Cargando…

Genetic Variations of AKT1 are Associated with Risk Screening for Non-Alcoholic Fatty Liver Disease

PURPOSE: Protein kinase B (PKB/AKT) has shown a high profile in the research of metabolic diseases. This research sought to determine whether the AKT1 gene’s single nucleotide polymorphisms (SNPs) and the risk of developing non-alcoholic fatty liver disease (NAFLD) were related. PATIENTS AND METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ding, Yajie, Tang, Zongzhe, Zhang, Ru, Zhang, Mengting, Guan, Qing, Zhang, Liuxin, Wang, Hongliang, Chen, Yue, Zhang, Wei, Wang, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387243/ https://www.ncbi.nlm.nih.gov/pubmed/37525829 http://dx.doi.org/10.2147/RMHP.S416592

Ejemplares similares

Genetic polymorphisms of Ca(2+) transport proteins and molecular chaperones in mitochondria-associated endoplasmic reticulum membrane and non-alcoholic fatty liver disease
por: Tang, Zongzhe, et al.
Publicado: (2023)

Combining serum uric acid and fatty liver index to improve prediction quality of nonalcoholic fatty liver disease
por: Ding, Yajie, et al.
Publicado: (2023)

Vitamin D Level and Vitamin D Receptor Genetic Variation Were Involved in the Risk of Non-Alcoholic Fatty Liver Disease: A Case-Control Study
por: Zhang, Ru, et al.
Publicado: (2021)

A combined association of serum uric acid, alanine aminotransferase and waist circumference with non-alcoholic fatty liver disease: a community-based study
por: Wang, Min, et al.
Publicado: (2022)

Genetic Polymorphism of Vitamin D Family Genes CYP2R1, CYP24A1, and CYP27B1 Are Associated With a High Risk of Non-alcoholic Fatty Liver Disease: A Case-Control Study
por: Wang, Minxian, et al.
Publicado: (2021)

Corrigendum: Genetic Polymorphism of Vitamin D Family Genes CYP2R1, CYP24A1, and CYP27B1 Are Associated With a High Risk of Non-alcoholic Fatty Liver Disease: A Case-Control Study
por: Wang, Minxian, et al.
Publicado: (2021)

External validation and comparison of simple tools to screen for nonalcoholic fatty liver disease in Chinese community population
por: Zhang, Liuxin, et al.
Publicado: (2022)

Association Between Triglyceride-Glucose Index and Risk of Metabolic Dysfunction-Associated Fatty Liver Disease: A Cohort Study
por: Zhang, Ru, et al.
Publicado: (2022)

Epidemiological characteristics of alcohol-related liver disease in China: a systematic review and meta-analysis
por: Tang, Zongzhe, et al.
Publicado: (2023)

Fat mass index as a screening tool for the assessment of non-alcoholic fatty liver disease
por: Zhang, Shengkui, et al.
Publicado: (2022)

Screening strategy for non-alcoholic fatty liver disease
por: Zhang, Saisai, et al.
Publicado: (2023)

Diagnostic and therapeutic strategies for non-alcoholic fatty liver disease
por: Fu, Yajie, et al.
Publicado: (2022)

Seabuckthorn polysaccharide combined with astragalus polysaccharide ameliorate alcoholic fatty liver by regulating intestinal flora
por: Liu, Jiayue, et al.
Publicado: (2022)

An Overview of the Mechanism of Penthorum chinense Pursh on Alcoholic Fatty Liver
por: Zhao, Xingtao, et al.
Publicado: (2020)

Establishment of the Tree Shrew as an Alcohol-Induced Fatty Liver Model for the Study of Alcoholic Liver Diseases
por: Xing, Huijie, et al.
Publicado: (2015)

Screening of co-pathogenic genes of non-alcoholic fatty liver disease and hepatocellular carcinoma
por: Chen, Ting, et al.
Publicado: (2022)

Role of Apolipoprotein A1 in PPAR Signaling Pathway for Nonalcoholic Fatty Liver Disease
por: Chen, Changxi, et al.
Publicado: (2022)

Effects of Bariatric Endoscopy on Non-Alcoholic Fatty Liver Disease: A Comprehensive Systematic Review and Meta-Analysis
por: Ren, Mengting, et al.
Publicado: (2022)

The role of SAMM50 in non‐alcoholic fatty liver disease: from genetics to mechanisms
por: Li, Zuyin, et al.
Publicado: (2021)

Effects of treatment of non-alcoholic fatty liver disease on heart failure with preserved ejection fraction
por: Yang, Zifeng, et al.
Publicado: (2023)

Variation in Alanine Aminotransferase in Children with Non-Alcoholic Fatty Liver Disease
por: Castillo-Leon, Eduardo, et al.
Publicado: (2022)

Complements are involved in alcoholic fatty liver disease, hepatitis and fibrosis
por: Lin, Cheng-Jie, et al.
Publicado: (2018)

Endocrine disrupting chemicals: A promoter of non-alcoholic fatty liver disease
por: Chen, Yajie, et al.
Publicado: (2023)

Yinzhihuang oral liquid protects against non-alcoholic steatohepatitis via modulation of the gut-liver axis in mice
por: Li, Shuyu, et al.
Publicado: (2022)

Non-alcoholic fatty liver disease: An expanded review
por: Benedict, Mark, et al.
Publicado: (2017)

Honokiol acts as an AMPK complex agonist therapeutic in non-alcoholic fatty liver disease and metabolic syndrome
por: Tian, Ruifeng, et al.
Publicado: (2023)

Assessment of the relationship between non‐alcoholic fatty liver disease and diabetic complications
por: Yan, Li‐hui, et al.
Publicado: (2016)

Evaluation of the feasibility of screening for paediatric non‐alcoholic fatty liver disease
por: Draijer, Laura, et al.
Publicado: (2022)

Screening New Blood Indicators for Non-alcoholic Fatty Liver Disease (NAFLD) Diagnosis of Chinese Based on Machine Learning
por: Wang, Cheng, et al.
Publicado: (2022)

Extracellular Vesicles in Non-alcoholic Fatty Liver Disease and Alcoholic Liver Disease
por: Wu, Dongqing, et al.
Publicado: (2021)

Alleviation of Alcoholic Fatty Liver by Dendrobium officinale Flower Extracts due to Regulation of Gut Microbiota and Short-Chain Fatty Acids in Mice Exposed to Chronic Alcohol
por: Zhang, Jingchi, et al.
Publicado: (2023)

The change of non-alcoholic fatty liver disease is associated with risk of incident diabetes
por: Chen, Congling, et al.
Publicado: (2023)

CRISPR-edited hepatic organoids as drug screening platform for non-alcoholic fatty liver disease
por: Wang, Yinhan, et al.
Publicado: (2023)

Remnant cholesterol, stronger than triglycerides, is associated with incident non-alcoholic fatty liver disease
por: Cheng, Yiping, et al.
Publicado: (2023)

Gut microbiota–mitochondrial inter-talk in non-alcoholic fatty liver disease
por: Zhang, Qi, et al.
Publicado: (2022)

Circadian Clock Genes in the Metabolism of Non-alcoholic Fatty Liver Disease
por: Shi, Dongmei, et al.
Publicado: (2019)

Lipid droplet dynamics in alcoholic fatty liver disease
por: Schulze, Ryan J., et al.
Publicado: (2019)

Advances in genetic variation in metabolism-related fatty liver disease
por: Shi, Fan, et al.
Publicado: (2023)

The Contribution of Dietary Fructose to Non-alcoholic Fatty Liver Disease
por: Yu, Siyu, et al.
Publicado: (2021)

Non-Alcoholic Fatty Liver Disease in Children: Focus on Nutritional Interventions
por: Yang, Min, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_sjbmo578j96t2jhear8rgspk3g